ArticleNagoya journal of medical science2025
Human dental pulp stem cells-derived small extracellular vesicles prevent osteoradionecrosis of the jaw in a rat model.
Article in Nagoya journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Telomerase-mediated immortalization preserves the anti-inflammatory activity of dental pulp stem cell extracellular vesicles.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiotherapy (RT) is an important standard treatment for head and neck cancer. On the other hand, osteoradionecrosis of the jaw (ORNJ), a side effect of RT, is intractable and has been a long-standing problem that needs to be overcome. Cellular senescence has been linked to the development of ORNJ; however, strategies for preventing and treating this disease have not been established. This study aimed to evaluate the effects of human dental pulp stem cell-derived small extracellular vesicles (hDPSC-sEV) on ORNJ. The effects of hDPSC-sEV treatment on rat bone marrow cells (rBMC) were examined in vitro. In addition, hDPSC-sEV were administered intravenously to a rat ORNJ model, and the extraction socket was examined radiologically and histologically. In vitro, rBMC treated with hDPSC-sEV immediately after irradiation showed downregulated expression of senescence-related genes. In vivo, the extraction sockets of the ORNJ models treated with hDPSC-sEV showed more new bone and greater coverage with gingiva relative to those observed in the comparison groups. This study suggests that hDPSC-sEV may inhibit ORNJ development. One possible mechanism is that hDPSC-sEV inhibit radiation-induced cellular senescence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.